HIV vaccines polytope - Bavarian Nordic/VaxOnco
Alternative Names: EP 1232; EP 1233; EP-1232 + EP-1233; HIV DNA vaccine + MVA HIV vaccine - Bavarian Nordic; MVA-BN Polytope; MVA-BN32; MVA-mBN32Latest Information Update: 24 Oct 2021
Price :
$50 *
At a glance
- Originator Bavarian Nordic; Pharmexa-Epimmune
- Developer Bavarian Nordic; VaxOnco
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 20 Apr 2012 Discontinued - Phase-I for HIV-1 infections in Germany (Parenteral)
- 20 Apr 2012 Discontinued - Phase-I for HIV-1 infections in USA (Parenteral)
- 20 Apr 2012 Discontinued - Phase-I/II for HIV-1 infections in Germany (Parenteral)